Zacks Research Comments on Westlake's Q3 Earnings (NYSE:WLK)

Key Points

• Zacks Research has revised its Q3 2025 EPS estimate for Westlake down from $0.35 to $0.28, while the full-year earnings estimate remains at $6.48 per share.
• Westlake recently reported a quarterly loss of ($0.09) EPS, missing expectations, with revenue declining 7.9% year-over-year to $2.95 billion.
• The company has increased its quarterly dividend to $0.53 per share, yielding 2.8% annually, following a previous dividend of $0.47.

Westlake Corporation (NYSE:WLK - Free Report) - Analysts at Zacks Research dropped their Q3 2025 EPS estimates for shares of Westlake in a research report issued on Thursday, September 25th. Zacks Research analyst Team now forecasts that the specialty chemicals company will earn $0.28 per share for the quarter, down from their prior estimate of $0.35. The consensus estimate for Westlake's current full-year earnings is $6.48 per share. Zacks Research also issued estimates for Westlake's Q4 2025 earnings at $0.01 EPS, Q1 2026 earnings at $0.35 EPS, Q2 2026 earnings at $1.06 EPS, Q3 2026 earnings at $1.35 EPS, FY2026 earnings at $2.70 EPS, Q1 2027 earnings at $0.87 EPS, Q2 2027 earnings at $1.55 EPS and FY2027 earnings at $4.24 EPS.

A number of other research firms have also recently commented on WLK. Tudor, Pickering, Holt & Co. raised Westlake from a "hold" rating to a "buy" rating and set a $90.00 target price on the stock in a research note on Wednesday, August 6th. Bank of America cut their price objective on Westlake from $90.00 to $84.00 and set a "buy" rating for the company in a report on Wednesday, June 18th. JPMorgan Chase & Co. raised their price objective on Westlake from $73.00 to $78.00 and gave the company a "neutral" rating in a report on Thursday. Wells Fargo & Company upped their target price on Westlake from $76.00 to $90.00 and gave the stock an "equal weight" rating in a research note on Monday, July 14th. Finally, Morgan Stanley reduced their price target on shares of Westlake from $98.00 to $90.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $92.64.

Westlake Price Performance

Shares of NYSE:WLK opened at $76.01 on Friday. The company's fifty day moving average price is $83.97 and its 200-day moving average price is $84.91. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.47 and a quick ratio of 1.75. The firm has a market capitalization of $9.75 billion, a price-to-earnings ratio of -143.41 and a beta of 0.92. Westlake has a one year low of $68.55 and a one year high of $151.56.

Westlake (NYSE:WLK - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The specialty chemicals company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.15). The business had revenue of $2.95 billion during the quarter, compared to analysts' expectations of $3 billion. Westlake had a negative net margin of 0.57% and a positive return on equity of 1.26%. The business's revenue was down 7.9% on a year-over-year basis. During the same period in the previous year, the business earned $2.40 EPS.

Hedge Funds Weigh In On Westlake

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Parallel Advisors LLC raised its holdings in shares of Westlake by 33.9% in the first quarter. Parallel Advisors LLC now owns 525 shares of the specialty chemicals company's stock worth $53,000 after buying an additional 133 shares during the period. Cetera Investment Advisers lifted its position in shares of Westlake by 4.7% during the fourth quarter. Cetera Investment Advisers now owns 3,007 shares of the specialty chemicals company's stock worth $345,000 after purchasing an additional 136 shares during the last quarter. PNC Financial Services Group Inc. increased its stake in Westlake by 11.8% in the 2nd quarter. PNC Financial Services Group Inc. now owns 1,433 shares of the specialty chemicals company's stock worth $109,000 after buying an additional 151 shares during the period. The Manufacturers Life Insurance Company boosted its position in Westlake by 0.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 28,134 shares of the specialty chemicals company's stock valued at $2,136,000 after buying an additional 165 shares during the period. Finally, Peterson Wealth Services raised its stake in shares of Westlake by 2.8% during the first quarter. Peterson Wealth Services now owns 6,578 shares of the specialty chemicals company's stock valued at $658,000 after acquiring an additional 178 shares in the last quarter. Hedge funds and other institutional investors own 28.40% of the company's stock.

Westlake Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 4th. Shareholders of record on Tuesday, August 19th were given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Tuesday, August 19th. This is an increase from Westlake's previous quarterly dividend of $0.47. Westlake's payout ratio is presently -400.00%.

Westlake Company Profile

Westlake Corporation engages in the manufacture and marketing of performance and essential materials, and housing and infrastructure products in the United States, Canada, Germany, China, Mexico, Brazil, France, Italy, Taiwan, and internationally. The company operates through two segments: Performance and Essential Materials and Housing and Infrastructure Products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.